Rationale: The mechanisms leading to an expanded neutrophil and monocyte supply after
stroke are incompletely understood. Objective: To test the hypothesis that transient middle …

There is currently no proposed stroke biomarker with consistent application in clinical
practice. A number of studies have examined cell-free DNA (cfDNA), which circulates in …

Objectives We aimed to evaluate the diagnostic value of the combination of the monocyte-to-
high-density lipoprotein cholesterol ratio (MHR) with the monocyte-to-lymphocyte ratio …

Abstract The microbiota engages in the development and maintenance of the host immune
system. The microbiota affects not only mucosal tissues where it localizes but also the distal …

Background Chemokine-like factor 1 (CKLF1) is a chemokine increased significantly in
ischemic brain poststroke. It shows chemotaxis effects on various immune cells, but the …

Background and Aims. White blood cell (WBC) and neutrophil counts (NC) are common
markers of inflammation and neurological stroke damage and could be expected to predict …

Introduction Higher white blood cell (WBC) count is associated with poor functional outcome
in acute ischemic stroke (AIS). However, little is known about whether the association is …

Background and purpose Sex and race disparities in recombinant tissue plasminogen
activator (rt-PA) use have been reported. We sought to explore sex and race differences in …

Ischemic stroke (IS) is a common neurological disease in the elderly, but the relationship
between neutrophil/albumin ratio (NAR) and leukocyte count/albumin ratio (LAR) and the …

Background and Purpose Ischemic stroke is a leading cause of mortality and disability
globally, necessitating accurate prediction of intra-hospital mortality (IHM) for improved …